This site is currently not optimized for mobile devices. For the best user experience, please access the site via a device with a wider screen such as a desktop or laptop.

For full functionality of this site it is necessary to enable JavaScript. Here are the instructions how to enable JavaScript in your web browser.

Once enabled, click here to view the site.

singup link button why should I sign up?
Login as Volunteer Login as Study team member
OR

Studies you may be eligible for. 23

Based on the information you provided, we found the following studies.

  • A Randomized Phase II Study of Adjuvant Trastuzumab emtansine (T-DM1) vs Paclitaxel in Combination with Trastuzumab (Herceptin┬«) for Stage I HER2-Positive Breast Cancer Goals: see if T-DMl will have less side-effects than traditional HER2-positive breast cancer treatment of trastuzumab + paclitaxel; learn about the long term benefits and disease-free survival of subjects who take T-DM1 compared to those subjects to take the combination of trastuzumab + paclitaxel. This study is researching all of the following topics: Breast cancer This study is looking for: male female both men and women Volunteers with specific conditions
    • More than 18 years old
  • A Randomized, Double-blind, Placebo-controlled Ph 2 Study of Paclitaxel in Combination with Reparixin Compared to Paclitaxel Alone as Front-line Therapy for Metastatic Triple-Negative Breast Cancer The main objective of this study is to compare the combination of paclitaxel plus new experimental drug reparixin, to paclitaxel without reparixin. This study will look for differences in both safety and effectiveness. This study is researching all of the following topics: Breast cancer This study is looking for: female only women Volunteers with specific conditions
    • More than 18 years old
  • A Phase 2 Study of investigational drug Abemaciclib in Patients with Brain Metastases Secondary to Hormone Receptor Positive Breast Cancer This study is being done to see how safe abemaciclib is and how well it will work to help people with breast cancer that has spread to the brain. This study is researching all of the following topics: Breast cancer This study is looking for: female only women Volunteers with specific conditions
    • More than 18 years old
  • Radium-223 dichloride vs. placebo when administered to metastatic HER2 negative hormone receptor positive breast cancer w/bone metastases treated w/hormonal treatment background therapy. (Bayer 16298) The study goal is to understand if adding radium-223 dichloride to the standard of care hormonal therapy helps subjects to survive longer with a delay in the occurrence of symptomatic skeletal events (SSEs).Radium-223 dichloride is considered an experimental drug for subjects with breast cancer. This study is researching all of the following topics: Breast cancer This study is looking for: male female both men and women Volunteers with specific conditions
    • More than 18 years old
  • Radium-223 dichloride in combination with exemestane and everolimus versus placebo in combination with exemastane and everolimus in metastatic HER2 breast cancer (Bayer 17096). The main goal of this study is to understand if adding experimental drug radium-223 dichloride to exemestane and everolimus helps subjects to delay the occurrence of symptomatic skeletal events (SSEs). This study is researching all of the following topics: Breast cancer This study is looking for: male female both men and women Volunteers with specific conditions
    • More than 18 years old
  • Clinical and biological characterization of Male Breast Cancer: an international EORTC, BIG, TBCRC and NABCG intergroup study The study goal is to create an international cancer registry, where information about male breast cancer will be stored, in order to better understand and treat male breast cancer. This study is researching all of the following topics: Breast cancer This study is looking for: male only men Volunteers with specific conditions
    • More than 18 years old
  • Phase 1, Open-Label, Dose-Escalation, Safety and Tolerability Study of investigational drug INCB054329 (Study Drug) in Subjects With Advanced Malignancies (INCB 54329-101) Study purpose:determine dose that is safe and tolerable and select the doses that will be studied further;understand how INCB054329 enters and leaves the body over time;understand how INCB054329 acts on and in the body;observe any effects INCB054329 may have on the growth of certain types of cancers This study is researching all of the following topics: ALL ( Acute lymphoblastic leukemia ) Breast cancer CLL ( Chronic lymphocytic leukemia) Colon Cancer ( Malignant tumor of colon ) Lung cancer Pancreatic cancer Prostate cancer This study is looking for: male female both men and women Volunteers with specific conditions
    • More than 18 years old
  • Phase III study of experimental drug LEE011 or placebo in combination w/tamoxifen/goserelin or NSAI/goserelin for TX of premenopausal women w/hormone receptor+, HER2-neg, advanced breast cancer. Study goal: learn whether LEE011 or placebo, when added to standard treatment (Tamoxifen + Goserelin or a non-steroidal aromatase inhibitor (NSAI) + Goserelin) helps reduce the growth of breast cancer cells in premenopausal women with hormone receptor positive, HER2-negative advanced breast cancer. This study is researching all of the following topics: Breast cancer This study is looking for: female only women Volunteers with specific conditions
    • 18 years to 60 years
  • Neratinib for Patients with HER2 + Breast Cancer and Brain Metastases The purpose of this research study is to determine how well neratinib works in treating breast cancer that has spread to the brain. This study is researching all of the following topics: Breast cancer This study is looking for: male female both men and women Volunteers with specific conditions
    • More than 18 years old
  • A Phase II Study of Neratinib in Metastatic HER2 Non-amplified but HER2 Mutant Breast Cancer The purpose of this research study is to test the cancer of women who have HER2┬┐negative to see if it has a HER2 mutation and, if so, see how the cancer responds to neratinib. This study is researching all of the following topics: Breast cancer This study is looking for: male female both men and women Volunteers with specific conditions
    • All ages welcome
Showing 1-10 of 23 studies
Show more studies